Sensorineural hearing loss, connexin 26 and 30 (GJB2 and GJB6 … see more Sensorineural hearing loss, connexin 26 and 30 (GJB2 and GJB6 genes)  see less
GTR Test Accession: Help GTR000591285.2
CAP
EAR, NOSE, THROATNERVOUS SYSTEMPSYCHIATRIC ... View more
Last updated in GTR: 2020-08-10
Last annual review date for the lab: 2024-07-31 LinkOut
At a Glance
Diagnosis; Mutation Confirmation
Sensorineural hearing loss disorder
Genes (2): Help
GJB2 (13q12.11); GJB6 (13q12.11)
Molecular Genetics - Mutation scanning of select exons: Bi-directional Sanger Sequence Analysis; ...
Not provided
Sensorineural hearing loss affects 1-2/1000 live newborns; 50% is from …
Establish or confirm diagnosis
Ordering Information
Offered by: Help
Molecular Genetics and Cytogenetics, Clinical Laboratory Service
View lab's website
Test short name: Help
Cx26 andCx30
Specimen Source: Help
  • Buccal swab
  • Isolated DNA
  • Peripheral (whole) blood
  • Saliva
Who can order: Help
  • Licensed Physician
Test Order Code: Help
2074
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 2
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 2
Method Category Help
Test method Help
Instrument *
Mutation scanning of select exons
Bi-directional Sanger Sequence Analysis
Targeted variant analysis
PCR
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Mutation Confirmation
Clinical validity: Help
Sensorineural hearing loss affects 1-2/1000 live newborns; 50% is from genetic origin, 70% corresponding to autosomal recessive non-syndromic symptoms . Half of them have pathogenic variants in GJB2 gene (Connexin 26). In some patients where one or none has been found variants in GJB2 gene, a 342-kb deletion in the … View more
View citations (1)
  • Connexin 26 and connexin 30 mutations in children with nonsyndromic hearing loss. Erbe CB, et al. Laryngoscope. 2004;114(4):607-11. doi:10.1097/00005537-200404000-00003. PMID: 15064611.
Clinical utility: Help
Establish or confirm diagnosis
View citations (1)
  • Connexin 26 and connexin 30 mutations in children with nonsyndromic hearing loss. Erbe CB, et al. Laryngoscope. 2004;114(4):607-11. doi:10.1097/00005537-200404000-00003. PMID: 15064611.

Variant Interpretation:
What is the protocol for interpreting a variation as a VUS? Help
ACMG-AMP guidelines for the interpretation of sequence variants, 2015 (PMID: 25741868).

Are family members with defined clinical status recruited to assess significance of VUS without charge? Help
Decline to answer.

Will the lab re-contact the ordering physician if variant interpretation changes? Help
Decline to answer.
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
29 patients with severe non-syndromic sensorineural hearing loss with autosomal recessive hereditary pattern were studied. The coding region of the GJB2 gene was studied by sequencing and deletion of the GJB6 gene by PCR. 38% of patients presented variants in both alleles, 3% in a single allele and 59% no … View more
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.